This ‘Feel Good’ ETF Is A Top ETF Performer This Year – Seeking Alpha
Seeking Alpha |
This 'Feel Good' ETF Is A Top ETF Performer This Year
Seeking Alpha But this has also been a year of medical breakthroughs, landmark approvals, and M&A activity in the cancer immunotherapy segment. The Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR) invests in this space, soaring more than 23% year to date and landing as … |
